ACTRN12622000629730已完成未知
Mamaku pith effects on the postprandial glycaemic response to carbohydrate food in healthy adults
ational Science Challenge - High Value Nutrition0 个研究点目标入组 16 人开始时间: 2022年4月28日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •Age: 18-65 years.
- •Sex: Any gender.
- •BMI between 18 and 35.
- •Health: Healthy as gauged by self-assessment and result on the General Health Questionnaire.
- •No indication of impaired glucose metabolism as indicated by fasting blood glucose and HbA1c determined on finger-prick samples.
- •Agreement: Participant having given written informed consent to comply with the conditions of the trial.
- •No allergic reaction to wheat products.
排除标准
- •Fasting blood glucose > 5.6 mmol/L and HbA1c > 40 mmol/mol
- •Allergic to or intolerant of wheat products.
- •Any gastrointestinal disorder.
- •Unwilling or unable to provide informed consent or comply with the study procedures.
- •Having Type I or II diabetes.
研究者
相似试验
尚未招募
Unknown
The acute effects of Saji juice on postprandial glucoseHealthy adultsJPRN-UMIN000045616Faculty of humanity-oriented science and engineering ,Kindai University10
已完成
Unknown
Investigation of the efficacy of Imeglimin on glycemic control and the underlying mechanismsJPRN-UMIN000049203Toho university15
已完成
不适用
Effects on postprandial blood glucose and triglyceride levels of confectionery made using Naked barley grown in Ehime prefecture for healthy subjects: crossover, placebo controlled randomized clinical trialPostprandial blood glucose and triglyceride levelsJPRN-UMIN000036141Ehime University40
已完成
1 期
Study on postprandial glycemic response of Glucomeal in type 2 diabetestype 2 diabetesT2DMTCTR20190917004Mega Lifesciences Public Company Limited15
已完成
1 期
Postprandial Glycemic Response of Glucomeal as Pre-meal (before breakfast) in Type 2 Diabetic PatientsType 2 diabetesT2DMTCTR20210429006Mega Lifesciences Public Company Limited15